Interestingly, as the entire myosin superfamily, its internal members have different roles in tumors; for example, MYO1A can inhibit gastrointestinal tumors (Mazzolini et al., 2013), while MYO1E can promote breast cancer invasion (Hallett et al., 2012). Here, MYO1A is linked to digestive system neoplasm.